Capital Asset Advisory Services’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-895
Closed -$108K 545
2022
Q3
$108K Buy
895
+51
+6% +$6.57K 0.01% 321
2022
Q2
$108K Buy
844
+38
+5% +$4.98K 0.01% 394
2022
Q1
$110K Buy
806
+144
+22% +$19.1K 0.01% 405
2021
Q4
$93K Sell
662
-343
-34% -$45.5K 0.01% 426
2021
Q3
$128K Sell
1,005
-35
-3% -$4.63K 0.01% 441
2021
Q2
$131K Hold
1,040
0.01% 465
2021
Q1
$121K Sell
1,040
-56
-5% -$6.46K 0.02% 450
2020
Q4
$124K Sell
1,096
-28
-2% -$3.06K 0.02% 412
2020
Q3
$118K Sell
1,124
-60
-5% -$6.32K 0.02% 331
2020
Q2
$125K Sell
1,184
-298
-20% -$29.4K 0.03% 354
2020
Q1
$146K Sell
1,482
-1,634
-52% -$159K 0.04% 299
2019
Q4
$325K Buy
+3,116
New +$300K 0.08% 255

Other funds holding XLV

Capital Asset Advisory Services's XLV Position: Q4 2022 in Review

Capital Asset Advisory Services sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2022, closing a stake of 895 shares — an estimated $108K sold.

Capital Asset Advisory Services first reported a position in XLV in Q4 2019 and held it in 12 quarters. The position peaked at $325K in Q4 2019. 1,606 funds tracked by Wall St. Rank hold XLV as of Q4 2022.

  • Capital Asset Advisory Services reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2022 after selling out during the quarter.
  • Capital Asset Advisory Services sold 895 State Street Health Care Select Sector SPDR ETF shares in Q4 2022, an estimated $108K.
  • Capital Asset Advisory Services first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2019 and held it in 12 quarters.
  • Capital Asset Advisory Services's State Street Health Care Select Sector SPDR ETF position peaked at $325K in Q4 2019.
  • 1,606 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2022.

Based on Capital Asset Advisory Services's 13F filing for Q4 2022, filed 8 Mar 2023.